A PYMNTS Company

US: Antitrust concerns bring subpoena to EpiPen maker

By  |  September 20, 2016

The day before the Congressional hearing on the rising price and absence of competition for the EpiPen, West Virginia Attorney General Patrick Morrisey confirmed that he had issued a subpoena to Mylan.

The maker of EpiPen was issued a subpoena in August seeking documents and other information related to EpiPen, but the company failed to meet the September 7 deadline.

The state believes that EpiPen has been short-changing the West Virginia Department of Health and Human Services Bureau for Medical Services by paying smaller rebates than it should have, which may constitute Medicaid fraud under state law.

Morrisey claims that Mylan currently controls up to 90% of the US market for epinephrine auto-injectors, which has allowed it to increase prices from around $100 for a two-pack back in 2009 to more than $600 for the same two-pack today.

Full Content: The Consumerist

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.